The modulation of ion channels, including NaV1.5, NaV1.7, and TRPV1, demonstrates the multifaceted approach that AMK may offer to address the diverse symptoms and pathophysiological mechanisms associated with IBS. The gene discussed is SCN9A; the disease is irritable bowel syndrome.